News
Aruvant Chooses Lonza to Manufacture ARU-1801, a Potentially Curative...
Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant’s one-time investigational...
News
ViGeneron inks research pact with Daiichi Sankyo to evaluate...
ViGeneron GmbH, a gene therapy company, announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited, for...
Drug Research
Novartis and GSK announce collaboration to support scientific research...
Novartis and GSK announced the launch of a collaboration to support high-quality scientific research investigating the link between genetic diversity across different regions in Africa...
News
NextPharma Set to Acquire Two Lonza Sites Specialized in...
“NextPharma is an established and well-respected company, with extensive experience in oral and topical finished dosage forms. As such, it is the ideal buyer given...
Clinical Trials
Intravacc announces completion of formulation and manufacturing process development...
Intravacc, a world leader in translational research and development of vaccines, announced that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and manufactured...
News
Brazil approves Sinovac and Astrazeneca Covid-19 vaccines for emergency...
Brazil has granted approval to AstraZeneca and Chinese firm Sinovac Biotech’c Covid-19 vaccines for emergency use, allowing the country to begin inoculation as cases surge.
Brazilian...
News
DARZALEX FASPRO Becomes the First FDA-Approved Treatment for Patients...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. FDA approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.